Fiche centre
Ottawa Memory Clinic
Ottawa — Canada
Essais liés2clinical trials
VilleOttawalocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04437511
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Donanemab | Alzheimer | Phase 3 | NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING |
| SNK01 | Alzheimer | Phase 1 | NCT06189963 | Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease | RECRUITING |